Company: IPSC
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-110851
Chunk: 3

Company: Century Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
 2025 and December 31, 2024, respectively​​ —​​ —​Common stock, $0.0001 par value, 300,000,000 shares authorized; 86,527,767 and 85,836,429 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively​​ 9​​ 9​Additional paid-in capital​  949,015​  943,366​Accumulated deficit ​​ (772,740)​​ (782,337)​Accumulated other comprehensive income​​ 64​​ 324​Total stockholders’ equity ​​ 176,348​​ 161,362​Total liabilities and stockholders’ equity​$ 244,717​$ 353,216​

​

See accompanying notes to the consolidated financial statements.

​

​